| NCT07142707 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity | RECRUITING | PHASE1 | 2025-09-03 | 2026-05-30 | 2026-05-30 |
| NCT07029412 | Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI) | RECRUITING | PHASE2 | 2025-08-26 | 2026-01-26 | 2025-12-22 |
| NCT06531941 | Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism | RECRUITING | PHASE2 | 2024-10-31 | 2027-05-27 | 2027-05-27 |
| NCT06465108 | Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-08-08 | 2025-07 | 2025-05 |
| NCT06496217 | Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function | RECRUITING | PHASE1 | 2024-05-24 | 2024-10-12 | 2024-10-12 |
| NCT06036784 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects | COMPLETED | PHASE1 | 2023-09-18 | 2024-12-05 | 2024-11-14 |
| NCT05158335 | Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects | COMPLETED | PHASE1 | 2021-11-10 | 2023-06-20 | 2023-06-20 |